Transcription of Long-Term Follow-Up Guidelines
{{id}} {{{paragraph}}}
Example: stock market
Long-Term Follow-Up Guidelines
Long-Term Follow-Up Guidelinesfor Survivors of Childhood, Adolescent, and Young Adult CancersVersion - October 2018 Website: 2018 Children s Oncology GroupAll rights reserved worldwideGenerously supported byWith special appreciation toJocelyn M. York, BA,Institute for Cancer Outcomes and SurvivorshipUniversity of Alabama at BirminghamBirmingham, AL for editing and typesettingLong-Term Follow-Up Guidelinesfor Survivors of Childhood, Adolescent, and Young Adult CancersVersion October 2018 Children s Oncology GroupAll rights reserved worldwideCOG LTFU Guidelines Page v Version October 2018 Section #PageSexTherapeutic AgentPotential Late Effect1418 FemaleAlkylating AgentsReduced ovarian follicular pool1520 Alkylating AgentsAcute myeloid leukemia; Myelodysplasia1621 Alkylating AgentsPulmonary fi brosis1722 Alkylating AgentsCataracts1823 Alkylating AgentsUrinary tract toxicity1924 Alkylating AgentsBladder malignancy2025 Alkylating AgentsRenal toxicity2126 Heavy MetalsOtotoxicity2228 Heavy MetalsPeripheral sensory neuropathy2329 Heavy MetalsRenal toxicity2430 AntimetabolitesNeurocognitive defi cits2531 AntimetabolitesNo known late effects (cytarabine [low dose IV, IO, IT, SQ])2632 AntimetabolitesHepatic dysfunction; Sinusoidal obstruction syndrome (SOS)2733 AntimetabolitesReduced bone mineral density (BMD)2835 Antimeta
4 5 Any Cancer Experience Psychosocial disability due to pain 5 6 Any Cancer Experience Fatigue; Sleep problems 6 7 Any Cancer Experience Limitations in healthcare and insurance access Blood/Serum Products 7 8 Diagnosed prior to 1972 Chronic hepatitis B 8 9 Diagnosed prior to 1993 Chronic hepatitis C 9 10 Diagnosed between 1977 and 1985 HIV ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: